Abstract
Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine (polyQ) disorder caused by a CAG repeat expansion in the ataxin-3 (ATXN3) gene resulting in toxic protein aggregation. Inflammation and oxidative stress are considered secondary factors contributing to the progression of this neurodegenerative disease. There is no cure that halts or reverses the progressive neurodegeneration of SCA3. Here we show that overexpression of cystathionine γ-lyase, a central enzyme in cysteine metabolism, is protective in a Drosophila model for SCA3. SCA3 flies show eye degeneration, increased oxidative stress, insoluble protein aggregates, reduced levels of protein persulfidation and increased activation of the innate immune response. Overexpression of Drosophila cystathionine γ-lyase restores protein persulfidation, decreases oxidative stress, dampens the immune response and improves SCA3-associated tissue degeneration. Levels of insoluble protein aggregates are not altered; therefore, the data implicate a modifying role of cystathionine γ-lyase in ameliorating the downstream consequence of protein aggregation leading to protection against SCA3-induced tissue degeneration. The cystathionine γ-lyase expression is decreased in affected brain tissue of SCA3 patients, suggesting that enhancers of cystathionine γ-lyase expression or activity are attractive candidates for future therapies.
Highlights
Spinocerebellar ataxia type 3 (SCA3), known as Machado-Joseph disease, is a rare progressive neurodegenerative disease and the most common dominantly inherited ataxia worldwide
To further investigate a possible modulating role of Cystathionine γ-lyase (CSE) in SCA3 pathogenesis, we investigated the effect of CSE overexpression in the SCA3 fly model
By using quantitative reverse transcriptase–polymerase chain reaction (qRT-PCR), we demonstrated that CSE1 showed a 2.1-fold induction of CSE compared with its isogenic control and that CSE2 and CSE3 showed a 2.2- and 5.3-fold increased expression of CSE compared with their isogenic control, respectively (Figures 3A, B)
Summary
Spinocerebellar ataxia type 3 (SCA3), known as Machado-Joseph disease, is a rare progressive neurodegenerative disease and the most common dominantly inherited ataxia worldwide. SCA3 is a polyglutamine (polyQ) disorder caused by a CAG-trinucleotide repeat expansion encoding glutamine within the sequence of the ataxin-3 (ATXN3) gene. The length of the repeat expansion is directly related to the aggregation propensity of the ataxin protein and is inversely related to the age of onset of the disease. Protein aggregates are considered to be the cause for neuronal dysfunction and death, which is supported by several lines of evidence showing that aggregate prevention or increased (autophagic) clearance delays neuronal death and degeneration in multiple model systems [1,2,3,4]. There are no disease-modifying treatments for polyQ diseases such as SCA3
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.